Item 2.02 Results of Operations and Financial Condition.

On May 12, 2023, Biofrontera Inc. (the "Company") issued a press release announcing its financial and operational results for the first quarter ended March 31, 2023. A copy of the press release is being furnished as Exhibit 99.1 attached hereto to this Current Report on Form 8-K.

The Company's press release contains non-GAAP financial measures. Generally, a non-GAAP financial measure is a numerical measure of a company's performance, financial position, or cash flows that either excludes or includes amounts that are not normally excluded or included in the most directly comparable measure calculated and presented in accordance with United States generally accepted accounting principles, or GAAP. Pursuant to the requirements of Regulation G, the Company has provided within the press release quantitative reconciliations of the non-GAAP financial measures to the most directly comparable GAAP financial measures.

The information contained in this Item 2.02 in the Current Report on Form 8-K (including Exhibit 99.1 attached hereto) is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liability of that section, nor shall such information be deemed to be incorporated by reference in any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

Item 5.02 Departure of Directors or Certain Officers; Election of Directors;


          Appointment of Certain Officers; Compensatory Arrangements of Certain
          Officers

On May 8, 2023, Erica Monaco, Chief Executive Officer of the Company notified the Company's Board of Directors that she intends to resign from the Company to pursue other opportunities. The Company and Ms. Monaco have agreed to discuss an appropriate transition period, including the effective date of her resignation.

Item 7.01 Regulation FD Disclosure

On May 12, 2023, the Company issued a press release announcing Ms. Monaco's resignation, a copy of which is attached here as Exhibit 99.2.

The information in Item 7.01 of this Current Report is being furnished and shall not be deemed "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. The information in this Current Report shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended.

Item 9.01 Financial Statements and Exhibits.






99.1     Press release dated May 12, 2023 relating to the Company's results for
       the quarter ended March 31, 2023
99.2     Press release dated May 12, 2023 relating to Ms. Monaco's resignation
104    Cover Page Interactive Data File (the cover page XBRL tags are embedded
       within the inline XBRL document)

© Edgar Online, source Glimpses